Advisory Committee on Complementary Medicines (ACCM)

Related information

18 January 2017

Role of the ACCM

The Advisory Committee on Complementary Medicines (ACCM) was formed in January 2010 to advise and make recommendations to the Therapeutic Goods Administration (TGA) on the safety, efficacy and manufacturing quality of a complementary medicine in the Australian Register of Therapeutic Goods.

The Committee is established under Regulation 39 of the Therapeutic Goods Regulations 1990 and the members are appointed by the Minister for Health. Further information on membership (including the chair) of the ACCM will be provided in early 2017.

ACCM supersedes the Complementary Medicines Evaluation Committee (CMEC) and has an increased focus on the advisory role within the regulatory framework of complementary medicines.

Membership comprises of professionals with specific scientific, medical, clinical expertise as well as appropriate consumer health issues relating to complementary medicines.

2017 ACCM proposed meeting dates

Meeting no. Meeting dates
17 16 June 2017
18 15 September 2017
19 8 December 2017

Contact details for the ACCM

Phone +61 2 6232 8734
Fax +61 2 6203 1250
Postal Address Advisory Committee on Complementary Medicines
Department of Health
MDP 71
GPO Box 9848
Canberra ACT 2601